Healthtech Growth Investors & VC Firms
1270 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
Pontifax Venture Capital
HerzeliyaSeed–Late Stage
7 people
Yamaha Motor Ventures
Palo AltoSeed–Growth$1M – $3M
13 people
MK Capital
NorthfieldSeed–Growth$2M – $10M
6 people
Siris
West Palm BeachGrowth–Late Stage$100M – $500M
18 people
Sovereign Capital Partners
LondonGrowth
28 people
TrueLight Capital
SingaporeSeed–Late Stage
28 people
Apposite Capital
LondonGrowth
21 people
Aroa Venture Partners
GurgaonSeed–Growth$100K – $500K
15 people
Questa Capital
San FranciscoGrowth$15M – $40M
15 people
Tal Ventures
Tel AvivPre-Seed–Late Stage
8 people
Fisher Lynch Capital
BurlingameGrowth
28 people
Merck Global Health Innovation Fund
RahwaySeed–Growth$10M
10 people
Chartwell Investments Entrepreneur & Founder Capital
New YorkGrowth$5M – $15M
21 people
Hadean Ventures
OsloSeed–Growth
21 people
Informed Ventures Advisors, Llc
Menlo ParkSeed–Late Stage
9 people
HBM Healthcare Investments
ZugGrowth
8 people
Magnetar AI Ventures
EvanstonGrowth
26 people
Miyako Capital
KyotoSeed–Late Stage
14 people
CapMan
HelsinkiGrowth–Late Stage$2.2M – $64.8M
19 people
Dimension Capital
San FranciscoSeed–Growth$1M – $10M
16 people
CREAS IMPACTO GLOBAL SGEIC
MadridSeed–Growth
21 people
Gulf Islamic Investments LLC (GII)
DubaiGrowth
26 people
Rite Ventures
StockholmSeries A–Growth
14 people
Waterline Ventures
CambridgeGrowth
14 people
Related lists
Growth Investors & VC Firms (4264)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Growth Investors & VC Firms in North America (2122)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.









































































































